Literature DB >> 19352334

Cardiovascular implications of proteinuria: an indicator of chronic kidney disease.

Varun Agrawal1, Victor Marinescu, Mohit Agarwal, Peter A McCullough.   

Abstract

Proteinuria, defined as urine protein excretion greater than 300 mg over 24 h, is a strong and independent predictor of increased risk for all-cause and cardiovascular mortality in patients with and without diabetes. Proteinuria is a sign of persistent dysfunction of the glomerular barrier and often precedes any detectable decline in renal filtration function. Measurement of proteinuria is important in stratifying the risk for cardiovascular disease and chronic kidney disease progression. A variety of basic pathophysiologic mechanisms that can partially explain simultaneous renal and cardiac disease will be discussed in this Review. In addition to being a prognostic marker, proteinuria is being considered as a therapeutic target in cardiovascular medicine. Therapeutic strategies for amelioration of proteinuria by achieving blood pressure targets, glycemic control in diabetes, treatment of hyperlipidemia, and reducing dietary salt and protein intake are also reviewed in this paper. Future clinical studies are needed to assess if proteinuria reduction should be a target of treatment to reduce the burden of end-stage renal disease, cardiovascular disease, and improve survival in this high-risk population.

Entities:  

Mesh:

Year:  2009        PMID: 19352334     DOI: 10.1038/nrcardio.2009.11

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


  100 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

Review 2.  Hyperlipidemia in patients with chronic renal disease.

Authors:  B L Kasiske
Journal:  Am J Kidney Dis       Date:  1998-11       Impact factor: 8.860

Review 3.  Chronic renal failure: a cardiovascular risk factor.

Authors:  Joan Fort
Journal:  Kidney Int Suppl       Date:  2005-12       Impact factor: 10.545

Review 4.  Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysis.

Authors:  Xiaolei Zhu; Shenhong Wu; William L Dahut; Chirag R Parikh
Journal:  Am J Kidney Dis       Date:  2007-02       Impact factor: 8.860

5.  Long-term renoprotective effects of standard versus high doses of telmisartan in hypertensive nondiabetic nephropathies.

Authors:  Pedro Aranda; Julian Segura; Luis M Ruilope; Francisco J Aranda; Miguel A Frutos; Verónica López; Eduardo López de Novales
Journal:  Am J Kidney Dis       Date:  2005-12       Impact factor: 8.860

6.  Coronary artery calcification scores in patients with chronic kidney disease prior to dialysis: reliability as a trial outcome measure.

Authors:  Katherine A Barraclough; Lesley A Stevens; Lee Er; Debbie Rosenbaum; Jacqueline Brown; Pari Tiwari; Adeera Levin
Journal:  Nephrol Dial Transplant       Date:  2008-05-01       Impact factor: 5.992

7.  The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide.

Authors:  H Buter; M H Hemmelder; G Navis; P E de Jong; D de Zeeuw
Journal:  Nephrol Dial Transplant       Date:  1998-07       Impact factor: 5.992

8.  Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: an open-label crossover randomized controlled trial.

Authors:  Leszek Tylicki; Przemysław Rutkowski; Marcin Renke; Wojciech Larczyński; Ewa Aleksandrowicz; Wiesława Lysiak-Szydlowska; Bolesław Rutkowski
Journal:  Am J Kidney Dis       Date:  2008-04-18       Impact factor: 8.860

9.  Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy.

Authors:  G L Bakris; M R Weir; V DeQuattro; F G McMahon
Journal:  Kidney Int       Date:  1998-10       Impact factor: 10.612

10.  Low-protein diet for diabetic nephropathy: a meta-analysis of randomized controlled trials.

Authors:  Yu Pan; Li Li Guo; Hui Min Jin
Journal:  Am J Clin Nutr       Date:  2008-09       Impact factor: 7.045

View more
  42 in total

Review 1.  Cardiovascular disease in chronic kidney disease: data from the Kidney Early Evaluation Program (KEEP).

Authors:  Peter A McCullough; Susan Steigerwalt; Kirit Tolia; Shu-Cheng Chen; Suying Li; Keith C Norris; Adam Whaley-Connell
Journal:  Curr Diab Rep       Date:  2011-02       Impact factor: 4.810

2.  A randomized trial of dietary sodium restriction in CKD.

Authors:  Emma J McMahon; Judith D Bauer; Carmel M Hawley; Nicole M Isbel; Michael Stowasser; David W Johnson; Katrina L Campbell
Journal:  J Am Soc Nephrol       Date:  2013-11-07       Impact factor: 10.121

3.  Is neutrophil lymphocyte ratio an indicator for proteinuria in chronic kidney disease?

Authors:  Emine Binnetoğlu; Erkan Şengül; Gökçen Halhallı; Sevim Dindar; Hacer Şen
Journal:  J Clin Lab Anal       Date:  2014-03-22       Impact factor: 2.352

Review 4.  Balancing calcium signals through TRPC5 and TRPC6 in podocytes.

Authors:  Anna Greka; Peter Mundel
Journal:  J Am Soc Nephrol       Date:  2011-10-06       Impact factor: 10.121

5.  Extracellular Vesicles from Albumin-Induced Tubular Epithelial Cells Promote the M1 Macrophage Phenotype by Targeting Klotho.

Authors:  Yijie Jia; Zongji Zheng; Meng Xue; Shuting Zhang; Fang Hu; Yang Li; Yanlin Yang; Meina Zou; Shuangshuang Li; Ling Wang; Meiping Guan; Yaoming Xue
Journal:  Mol Ther       Date:  2019-06-04       Impact factor: 11.454

6.  Multidetector computed tomography findings and correlations with proteinuria in nutcracker syndrome.

Authors:  Byoung Soo Cho; Jin Soon Suh; Won Ho Hahn; Sung Do Kim; Joo Won Lim
Journal:  Pediatr Nephrol       Date:  2009-12-18       Impact factor: 3.714

7.  Dendrin ablation prolongs life span by delaying kidney failure.

Authors:  Astrid Weins; Jenny S Wong; John M Basgen; Ritu Gupta; Ilse Daehn; Lisette Casagrande; David Lessman; Monica Schwartzman; Kristin Meliambro; Jaakko Patrakka; Andrey Shaw; Karl Tryggvason; John Cijiang He; Susanne B Nicholas; Peter Mundel; Kirk N Campbell
Journal:  Am J Pathol       Date:  2015-06-12       Impact factor: 4.307

8.  Proteinuria in sarcoidosis: Prevalence and risk factors in a consecutive outpatient cohort.

Authors:  Amit Chopra; Paul Brasher; Haroon Chaudhry; Robert Zheng; Arif Asif; Marc A Judson
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

Review 9.  Pathophysiology of proteinuria and its value as an outcome measure in chronic kidney disease.

Authors:  Paolo Cravedi; Giuseppe Remuzzi
Journal:  Br J Clin Pharmacol       Date:  2013-10       Impact factor: 4.335

Review 10.  Cardiovascular risk factors in patients with chronic kidney disease.

Authors:  Sarina van der Zee; Usman Baber; Sammy Elmariah; Jonathan Winston; Valentin Fuster
Journal:  Nat Rev Cardiol       Date:  2009-07-21       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.